secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001174947-25-000654
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q1 adjusted EPS $0.95, revenue $321.3M, raises FY2025 guidance
---------------------------------------------------------------------

- Total sales $321.3M, up 2.9% reported (3.8% constant currency); domestic +4.2%, international +1.2%.
- GAAP diluted EPS $0.19 vs $0.63 YoY, hit by $12.2M executive transition costs and $4.0M contingent consideration.
- Adjusted diluted EPS $0.95, up 20% from $0.79; adjusted EBITDA $61.3M (19.1% margin) vs $56.3M.
- FY2025 revenue guidance raised to $1.350-1.378B (prior $1.344-1.372B); adjusted EPS raised to $4.45-4.60 (prior $4.25-4.40).
- Company estimates ~$0.14 negative tariff impact on EPS in H2 2025, not included in updated guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000654/0001174947-25-000654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494725000654/form8k-34170_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-25-000654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer